XML 74 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Debt (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 24, 2019
Jun. 30, 2019
Jan. 31, 2019
Jun. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Jun. 27, 2018
Debt                  
Line of credit (current)         $ 250.0   $ 250.0    
Debt issuance costs             0.7 $ 13.2  
Arena Pharmaceuticals, Inc.                  
Debt                  
Upfront payment $ 800.0   $ 800.0            
Credit Agreement                  
Debt                  
Borrowing 800.0                
Period of extension in maturity   1 year     1 year        
Debt aggregate principal value                 $ 250.0
Interest expense         $ 11.7 $ 4.1 34.2 9.6  
Upfront payment $ 800.0                
Outstanding Balance         $ 1,000.0   1,000.0    
Line of credit repaid during the period             $ 50.0    
Debt issuance costs       $ 13.2          
Debt issuance costs capitalized       12.6          
First unsecured revolving credit facility                  
Debt                  
Borrowing           1,000.0   1,000.0  
Second unsecured revolving credit facility                  
Debt                  
Borrowing           $ 500.0   $ 500.0  
Increase in borrowing capacity       $ 300.0